- Home
- TIL vs LFVN Comparison
TIL vs LFVN Comparison
Compare TIL & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- LFVN
- Stock Information
- Founded
- TIL 2018
- LFVN N/A
- Country
- TIL United States
- LFVN United States
- Employees
- TIL N/A
- LFVN N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- TIL Health Care
- LFVN Health Care
- Exchange
- TIL Nasdaq
- LFVN Nasdaq
- Market Cap
- TIL 177.1M
- LFVN 162.8M
- IPO Year
- TIL 2021
- LFVN N/A
- Fundamental
- Price
- TIL $31.50
- LFVN $12.11
- Analyst Decision
- TIL Buy
- LFVN Strong Buy
- Analyst Count
- TIL 6
- LFVN 2
- Target Price
- TIL $120.50
- LFVN $30.50
- AVG Volume (30 Days)
- TIL 109.0K
- LFVN 124.8K
- Earning Date
- TIL 08-13-2025
- LFVN 10-28-2025
- Dividend Yield
- TIL N/A
- LFVN 1.49%
- EPS Growth
- TIL N/A
- LFVN 226.09
- EPS
- TIL N/A
- LFVN 0.75
- Revenue
- TIL N/A
- LFVN $228,530,000.00
- Revenue This Year
- TIL N/A
- LFVN $12.65
- Revenue Next Year
- TIL N/A
- LFVN $12.43
- P/E Ratio
- TIL N/A
- LFVN $16.15
- Revenue Growth
- TIL N/A
- LFVN 14.17
- 52 Week Low
- TIL $10.80
- LFVN $8.17
- 52 Week High
- TIL $92.00
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- TIL 61.57
- LFVN 39.28
- Support Level
- TIL $26.69
- LFVN $12.47
- Resistance Level
- TIL $28.85
- LFVN $14.28
- Average True Range (ATR)
- TIL 2.16
- LFVN 1.00
- MACD
- TIL 0.43
- LFVN -0.06
- Stochastic Oscillator
- TIL 76.70
- LFVN 45.48
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.